RESTYLANE SHAYPE
Live / Applied — Second extension granted (statement of use) (as of 26 Jan 2026)
What this means for you
Not registered yet, but its 24 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98237535
- Mark type
- Stylized text
- Filed
- 24 Oct 2023
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Katherine P. Califa
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances, namely, creams and gels for use in dermatology; injectable pharmaceutical products for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; injectable dermal fillers; pharmaceutical preparations and substances, namely, creams and gels for use in skin care; muscle relaxants; medicinal preparations for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; medical preparations consisting of a dermatological preparation; pre-filled syringes and vials, for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; skin-care kits comprising dermatological preparations, and pre-filled syringes and vials, for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin, sold together as a unit; pharmaceutical preparations for use in non-surgical restorative and beauty care treatments and in aesthetic dermatology; synthetic injectable material for use in the treatment of fine lines and wrinkles and for rejuvenating the skin
- Class 010 — Medical apparatus: Medical devices, namely, synthetic implants in gel form; medical devices, namely, synthetic implants in gel form for treating lines, wrinkles, scars, lips, for tightening the face and body and for rejuvenating the skin; skin care kits comprising medical devices, namely, synthetic implants in gel form for treating lines, wrinkles, scars, lips, for tightening the face and body and for rejuvenating the skin; injection syringes, and injection devices for pharmaceutical products, sold together as a unit; injection syringes; injection devices for pharmaceutical products
Owner
- Galderma Holding SA, Zug, CH
- Galderma Holding SA, Zug, CH
Prosecution history
- 27 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jan 2026 — SOU EXTENSION 2 GRANTED
- 26 Jan 2026 — SOU EXTENSION 2 FILED
- 26 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2025 — SOU EXTENSION 1 GRANTED
- 18 Jun 2025 — SOU EXTENSION 1 FILED
- 18 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Nov 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS